Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$130.52M
Total Bought:
$16.70M
Total Sold:
$13.76M
Net Transaction:
+$2.95M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Atea Pharmaceuticals, Inc.(AVIR)7,609,8127,609,8120$22.75M$27.40M20.99%+$4.64M
Third Harmonic Bio Inc3,824,4173,824,4170$13.27M$20.77M15.91%+$7.50M
Aclaris Therapeutics, Inc.(ACRS)14,250,00014,250,0000$21.80M$20.23M15.50%-$1.57M
Instil Bio, Inc.(TIL)416,720534,899+118,179$7.23M$11.14M8.54%+$3.91M
Essa Pharma Inc4,221,5464,221,5460$6.67M$7.18M5.50%+$506.6K
Oramed Pharmaceuticals Inc.(ORMP)3,020,7483,083,253+62,505$6.46M$6.94M5.32%+$472.9K
Adverum Biotechnologies Inc2,742,3173,057,526+315,209$11.98M$6.57M5.04%-$5.41M
Ikena Oncology Inc3,710,8034,030,102+319,299$4.75M$5.40M4.14%+$650.5K
PMV Pharmaceuticals, Inc.(PMVP)3,747,6125,000,000+1,252,388$4.08M$5.30M4.06%+$1.22M
Alumis Inc49,6271,210,415+1,160,788$304.7K$3.63M2.78%+$3.33M
Kezar Life Sciences Inc
COM NEW
408,138635,183+227,045$1.99M$2.91M2.23%+$917.4K
Lava Therapeutics NvSHS1,960,6101,970,610+10,000$2.49M$2.60M1.99%+$111.2K
Milestone Pharmaceuticals Inc.(MIST)1,136,0911,136,0910$909.0K$2.20M1.69%+$1.30M
Elevation Oncology Inc5,890,9345,890,434-500$1.53M$2.16M1.66%+$636.0K
Connect Biopharma Hldgs LtdADS2,093,2321,821,558-271,674$1.15M$1.79M1.37%+$633.8K
Astrotech Corp220,410220,4100$1.43M$1.27M0.98%-$155.4K
Athira Pharma Inc3,200,6673,230,667+30,000$911.9K$975.7K0.75%+$63.8K
Lisata Therapeutics, Inc.(LSTA)216,853209,814-7,039$509.6K$608.3K0.47%+$98.7K
Corvus Pharmaceuticals, Inc.(CRVS)0118,766+118,766$0$475.1K0.36%+$475.1K
Turnstone Biologics Corp1,103,3861,103,3860$452.4K$396.1K0.30%-$56.3K
Vistagen Therapeutics, Inc.(VTGN)150,000150,0000$375.0K$300.0K0.23%-$75.0K
Hillevax Inc20,76091,913+71,153$30.1K$182.9K0.14%+$152.8K
Verrica Pharmaceuticals Inc.(VRCA)174,651174,6510$77.2K$92.6K0.07%+$15.4K
Whitehawk Therapeutics, Inc.(WHWK)1,890,2450-1,890,245$3.36M$0—-$3.36M
Achilles Therapeutics PlcADS3,804,9210-3,804,921$0$0—$0
An2 Therapeutics Inc5,749,4320-5,749,432$7.82M$0—-$7.82M
Nextcure Inc273,5360-273,536$131.4K$0—-$131.4K
Sage Therapeutics Inc135,0950-135,095$1.07M$0—-$1.07M
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q2 2025 | TickerTrail